Webinar I April 17, 2024
DISCOVER therapeutic antibodies: kinetics of antibody-drug conjugates measured directly on cells
This is the third episode of our second season of the DISCOVER MOLECULAR INTERACTIONS webinar series. Each month we will talk about cutting-edge drug discovery topics like bispecific antibodies, PROTACs or small molecules targeting RNA. We will show you how to characterize the respective molecular interactions in depth, how to create assays with remarkable biological similarity, low sample consumption, high versatility and exceptional ease-of-use. In this episode, Marc-André Kasper, Vice president for Chemistry and Early Discovery at Tubulis GmbH, joins us and showcases a new generation of antibody-drug conjugates. You will learn how Tubulis used Real-Time Interaction Cytometry (RT-IC) to measure kinetics directly on cells to support their ADC development. Furthermore, switchSENSE® was used to compare the relative size of ADCs and to draw conclusions on their tumor penetration capabilities. If you are interested in another application, you can find all future episodes of this webinar series here: